Now showing items 1-1 of 1

    • Ethics of a partially effective dengue vaccine: Lessons from the Philippines 

      Halstead B. S.; Katzelnick L. C.; Russell P. K.; Markoff L.; Aguiar M.; Dans L. R.; Dans A L. (Vaccine, 2020-07)
      Dengvaxia, a chimeric yellow fever tetravalent dengue vaccine developed by SanofiPasteur is widely licensed in dengue-endemic countries. In a large cohort study Dengvaxia was found to partially protect children who had ...